These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 16650180)
1. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. Kapp A; Pichler WJ Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180 [TBL] [Abstract][Full Text] [Related]
2. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787 [TBL] [Abstract][Full Text] [Related]
3. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study. Zuberbier T; Oanta A; Bogacka E; Medina I; Wesel F; Uhl P; Antépara I; Jáuregui I; Valiente R; Allergy; 2010 Apr; 65(4):516-28. PubMed ID: 19860762 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of levocetirizine in improving symptoms and health-related quality of life in US adults with seasonal allergic rhinitis: a randomized, placebo-controlled study. Segall N; Gawchik S; Georges G; Haeusler JM Ann Allergy Asthma Immunol; 2010 Mar; 104(3):259-67. PubMed ID: 20377116 [TBL] [Abstract][Full Text] [Related]
7. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. de Blic J; Wahn U; Billard E; Alt R; Pujazon MC Pediatr Allergy Immunol; 2005 May; 16(3):267-75. PubMed ID: 15853959 [TBL] [Abstract][Full Text] [Related]
8. Non-sedating antihistamines in the treatment of chronic idiopathic urticaria using patient-reported outcomes. Grob JJ; Lachapelle JM Curr Med Res Opin; 2008 Aug; 24(8):2423-8. PubMed ID: 18651988 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. Potter PC; Ann Allergy Asthma Immunol; 2005 Aug; 95(2):175-80. PubMed ID: 16136768 [TBL] [Abstract][Full Text] [Related]
10. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. Bachert C; Bousquet J; Canonica GW; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB; Van Hammée G; J Allergy Clin Immunol; 2004 Oct; 114(4):838-44. PubMed ID: 15480324 [TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of cetirizine and levocetirizine in chronic idiopathic urticaria. Garg G; Thami GP J Dermatolog Treat; 2007; 18(1):23-4. PubMed ID: 17365263 [TBL] [Abstract][Full Text] [Related]
12. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Walter Canonica G; Bousquet J; Van Hammée G; Bachert C; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB; Respir Med; 2006 Oct; 100(10):1706-15. PubMed ID: 16723217 [TBL] [Abstract][Full Text] [Related]
13. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Kaplan AP; Spector SL; Meeves S; Liao Y; Varghese ST; Georges G Ann Allergy Asthma Immunol; 2005 Jun; 94(6):662-9. PubMed ID: 15984599 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study. Dubertret L; Murrieta Aguttes M; Tonet J J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144 [TBL] [Abstract][Full Text] [Related]
15. H1-antihistamine treatment in young atopic children: effect on urticaria. Simons FE; Ann Allergy Asthma Immunol; 2007 Sep; 99(3):261-6. PubMed ID: 17910330 [TBL] [Abstract][Full Text] [Related]
16. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Lennox RD; Leahy MJ Ann Allergy Asthma Immunol; 2004 Aug; 93(2):142-6. PubMed ID: 15328673 [TBL] [Abstract][Full Text] [Related]
17. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis. Lee CF; Sun HL; Lu KH; Ku MS; Lue KH Pediatr Allergy Immunol; 2009 Aug; 20(5):493-9. PubMed ID: 19175892 [TBL] [Abstract][Full Text] [Related]
18. Levocetirizine for chronic idiopathic urticaria: a review. Ducharme EE; Weinberg JM J Drugs Dermatol; 2009 Mar; 8(3):243-7. PubMed ID: 19271371 [TBL] [Abstract][Full Text] [Related]
19. Safety of levocetirizine treatment in young atopic children: An 18-month study. Simons FE; Pediatr Allergy Immunol; 2007 Sep; 18(6):535-42. PubMed ID: 17561929 [TBL] [Abstract][Full Text] [Related]
20. Levocetirizine improves nasal symptoms and airflow in patients with persistent allergic rhinitis: a pilot study. Ciprandi G; Cirillo IG; Vizzaccaro A; Tosca MA Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):25-9. PubMed ID: 15745374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]